Paul Tudor Jones's ODTX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 44,171 shares of Odyssey Therapeutics, Inc. (ODTX) worth $826,439, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in ODTX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Odyssey Therapeutics (ODTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Odyssey Therapeutics (ODTX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +44,171 | New Buy | 44,171 | $18.71 |
Paul Tudor Jones's Odyssey Therapeutics Investment FAQs
Paul Tudor Jones first purchased Odyssey Therapeutics, Inc. (ODTX) in Q2 2026, acquiring 44,171 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Odyssey Therapeutics, Inc. (ODTX) for 1 quarters since Q2 2026.
Paul Tudor Jones's largest addition to Odyssey Therapeutics, Inc. (ODTX) was in Q2 2026, adding 44,171 shares worth $826,439.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 44,171 shares of Odyssey Therapeutics, Inc. (ODTX), valued at approximately $826,439.
As of the Q2 2026 filing, Odyssey Therapeutics, Inc. (ODTX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Odyssey Therapeutics, Inc. (ODTX) was 44,171 shares, as reported at the end of Q2 2026.